Management

Dr. Zadno has served as our President and Chief Executive Officer and a member of our board of directors since February 2020. He previously served as President and Chief Executive Officer of Avedro, Inc., a ophthalmology company, from September 2016 to November 2020, where he also served as a member of the board of directors from September 2016 to November 2020. Dr. Zadno also previously served as Innovation Advisor and Venture Partner at InterWest Partners, a venture capital firm, from January 2012 to January 2018. Dr. Zadno has also served on the boards of directors of Invuity, Inc. from January 2013 to June 2017, where he was a member of the audit committee, and Carbylan Therapeutics, Inc. from June 2013 to November 2016, where he was a member of the audit committee. In addition, Dr. Zadno has served as a public trustee on the board of the American Academy of Ophthalmology, since January 2024. Dr. Zadno received both a Ph.D. and an M.Sc. in Mechanical Properties of Materials (Metallurgy) from Ecole Nationale Superieure des Mines de Paris.

Mr. Waters has served as our EVP, Chief Financial Officer since January 2022. He previously served as our SVP, Chief Financial Officer from October 2018 until December 2021. Prior to joining PROCEPT BioRobotics Mr. Waters served as Chief Financial Officer at Accuray Inc., a radiation oncology company, from September 2015 to October 2018. In addition to his experience at Accuray, Inc., Mr. Waters held financial leadership positions at three publicly traded medical device companies, including Conceptus, Laserscope and VISX. These companies were all sold to strategic acquirers, generating approximately $3 billion in shareholder value. Mr. Waters began his career at PricewaterhouseCoopers, LLP. and received a B.S. in Business Administration, with a double concentration in Accounting and Finance from Cal Poly San Luis Obispo

Mr. Shiblaq has served as our EVP, Chief Commercial Officer since January 2022. He previously served as our SVP, Global Commercialization from March 2019 until December 2021. Prior to joining PROCEPT BioRobotics, Mr. Shiblaq served as Vice President of Commercial Operations at Invuity, Inc., the leader in advanced photonics and single-use, lighted instruments, until its acquisition by Stryker from January 2017 to January 2019. Prior to Invuity, Mr. Shiblaq served as Vice President of Sales at Analogic Corporation from June 2016 to January 2017. Mr. Shiblaq also held sales and commercial leadership positions at Intuitive Surgical, where he was responsible for driving the growth of emerging procedures in General, Thoracic and Gynecologic Surgery. Prior to Intuitive Surgical, Mr. Shiblaq held various Commercial leadership positions at Conceptus Inc., until its acquisition by Bayer AG. Mr. Shiblaq received a B.A. in Psychology from Ohio State University.

Ms. Nouri has served as our EVP, Chief Legal Officer & Corporate Secretary since January 2022. She has also served as our Chief Compliance Officer since September 2018. She previously served as our SVP, General Counsel & Corporate Secretary from July 2018 until December 2021. Prior to joining PROCEPT BioRobotics, Ms. Nouri served as Senior Vice President, General Counsel, Corporate Secretary and Chief Compliance Officer at Accuray Inc., a radiation oncology company, from February 2014 to July 2018. In her more than 15-year legal career in private practice law firms and with corporations as in-house counsel, Ms. Nouri has advised on corporate, transactional, and regulatory compliance matters including corporate governance, strategic transactions, mergers and acquisitions, intellectual property portfolio management, public disclosure issues, and SEC reporting and compliance. Ms. Nouri received a J.D. from U.C. College of the Law, San Francisco (formerly U.C. Hastings College of Law) and a Bachelor of Commerce in International Business and also completed the requirements for a finance specialization from the University of British Columbia.

Mr. Templin has over 15 years of experience in clinical research, engineering, and market development, primarily within the medical device industry. Most recently, he served as the VP of Clinical Research, Engineering, and Therapy Development for CardioKinetix. Prior to CardioKinetix, Mr. Templin was the Global Clinical Program Director for Abbott Vascular. He also led the landmark vulnerable plaque natural history study, PROSPECT. Prior to that role, Mr. Templin held engineering roles with GE Aircraft Engines and Guidant, and then clinical positions with Guidant (that was later acquired by Abbott). Mr. Templin holds a BS in Mechanical Engineering and minor in Economics from Rose-Hulman Institute of Technology and an MBA from Duke.

Mr. Chandran brings 20 years of combined experience in quality assurance, regulatory affairs, test engineering, and program management.  He has a passion for bringing new and disruptive technologies to market by building compliant yet flexible RAQA infrastructure based on product and business for both US and Int’l markets.  Mr. Chandran has held quality and regulatory leadership positions at numerous medical device companies, including Stryker Endoscopy, Siemens Ultrasound, Arthrocare Corporation (Smith & Nephew), InSound Medical (Phonak), myoscience & R2 Dermatology.  He has a BE in Electronics and Communications Engineering from India and has an MS in Electrical Engineering from University of Texas at Austin and is also a Stanford Certified Project Manager (SCPM).

Mr. Sancheti has been in operations leadership positions for over 15 years and has over 30 years of manufacturing, supply chain, engineering and operations experience in medical devices including vascular implants, catheters, RF ablation, respiratory assist devices and Robotic Assisted Surgery.  Prior to joining PROCEPT BioRobotics, he served as VP, Manufacturing Operations at Intuitive Surgical, among other leadership positions he held there.  Previously, Mr. Sancheti held VP Operations roles at Altura Medical, Ceterix Orthopedics, Breathe Technologies and VNUS Medical Technologies.  He holds a Bachelor of Science in Mechanical Engineering from the Birla Institute of Technology and Science in India, and a Master of Science in Manufacturing Engineering from the University of Massachusetts.

Ms. Porter joined PROCEPT BioRobotics in January 2024 and serves as our Chief People Officer. Prior to joining PROCEPT BioRobotics she was Chief People Officer of Outset Medical from January 2024 through October 2021, and their Vice President of People Operations beginning in October 2018. Prior to Outset, she was the Head of Global Talent Development for Intuitive Surgical, Inc., responsible for designing performance and succession practices, while developing leaders and high performing teams. Stacey has held leadership roles at VMware and Roche, and has built a career on creating nimble, progressive organizations. She has a MSW and doctoral studies in industrial/organizational psychology and is a sought-after speaker on building high performance cultures and developing skills for the future workplace.